Electrocardiographic and echocardiographic findings in street children known to be substance abusers

Cardiology in the Young

Volumn 18, Issue 1, 2008, Pages 58-61

  Olgar, Seref ^a   Dindar, Aygun ^a   Ertugrul, Turkan ^a   Omeroglu, Rukiye Eker ^a   Aydogan, Umrah ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Cardiomyopathy; Drug abuser; Glue sniffer; Sudden death; Volatile substance abuse

Indexed keywords

ALCOHOL; ANTIEMETIC AGENT; CANNABIS; COCAINE; GLUE; MORPHINE; MORPHINE DERIVATIVE; THINNER;

ADOLESCENT; ALCOHOL ABUSE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CANNABIS ADDICTION; CIGARETTE SMOKING; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG ABUSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FIRST DEGREE ATRIOVENTRICULAR BLOCK; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE SIZE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORPHINE ADDICTION; QT PROLONGATION; SINUS TACHYCARDIA; STATISTICAL SIGNIFICANCE; SUBSTANCE ABUSE;

ADOLESCENT; CHILD; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART DISEASES; HEART RATE; HEART VENTRICLES; HOMELESS YOUTH; HUMANS; MALE; PREVALENCE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SUBSTANCE-RELATED DISORDERS; TURKEY; VENTRICULAR FUNCTION, LEFT;

EID: 38949105450     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951107001710     Document Type: Article

References (23)

1. Anderson HR, Macnair RS, Ramsey JD. Deaths from abuse of volatile substances: A national epidemiological study. Br Med J (Clin Res Ed) 1985; 290: 304-307.
2. Anderson CE, Loomis GA. Recognition and prevention of inhalant abuse. Am Fam Physician 2003; 68: 869-874.
3. Garson A. How to measure the QT interval - what is normal. Am J Cardiol 1993; 72: 14B.
4. Watson JM. Solvent abuse by children and young adults: A review. Br J Addict 1980; 75: 27-36.
5. Meadows R, Verghese A. Medical complications of glue sniffing. South Med J 1996; 89: 455-462.
6. Uzun N, Kendirli Y. Clinical, socio-demographic, neurophysiological and neuropsychiatric evaluation of children with volatile substance addiction. Child Care Health Dev 2005; 31: 425-432.
7. Ramsey J, Anderson HR, Bloor K, Flanagan RJ. An introduction to the practice, prevalence and chemical toxicology of volatile substance abuse. Hum Toxicol 1989; 8: 261-269.
8. Esmail A, Warburton B, Bland JM, Anderson HR, Ramsey J. Regional variations in deaths from volatile solvent abuse in Great Britain. Addiction 1997; 92: 1765-1771.
9. de Carvalho FT, Neiva-Silva L, Ramos MC, et al. Sexual and drug use risk behaviors among children and youth in street circumstances in Porto Alegre. Brazil AIDS Behav 2006; 10: S57-S66.
10. Lolin Y. Chronic neurological toxicity associated with exposure to volatile substances. Hum Toxicol 1989; 8: 293-300.
11. Viccellio P. Abuse of volatile substances. In: Bania T, Brent J, Hoffman RS, Kulig KW, Mofenson HC, Osborn HH, Wang RY, Wax PM (eds). Emergency Toxicology 1998. Lippincott-Raven, Philadelphia, 1998, pp 925-932.
12. Langrod JG. Volatile substances. In: Lowison JH, Ruiz P, Millman RB, Langrod JG (eds). Substance abuse: A comprehensive textbook 1992. Williams & Wilkins, Baltimore, 1992, pp 303-327.
13. Cunningham SR, Dalzell GW, McGirr P, Khan MM. Myocardial infarction and primary vectricular fibrillation after glue sniffing. Br Med J (Clin Res Ed) 1987; 294: 739-740.
14. Straus SMJM, Kors JA, De Bruin ML, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol 2006; 47: 362-367.
15. Downes MA, Whyte IM, Isbister GK. QTc abnormalities in deliberate self-poisoning with Moclobemide Intern Med J 2005; 35: 388-391.
16. Lorsheyd A, de Lange DW, Hijmering ML, Cramer MJ, van de Wiel A. PR and QTc interval prolongation on the electrocardiogram after binge drinking in healthy individuals. Neth J Med 2005; 63: 59-63.
17. Fitzgerald JL, Reid JJ. Sympathomimetic actions of methylene-dioxymethamphetamine in rat and rabbit isolated cardiovascular tissues. J Pharm Pharmacol 1994; 46: 826-832.
18. Krantz MJ, Lewkowiez L, Hays H, Woodroffe MA, Robertson AD, Mehler PS. Torsade de pointes associated with very-high-dose methadone. Ann Intern Med 2002; 137: 501-504.
19. Martell BA, Arnsten JH, Ray B, Gourevitch MN. The impact of methadone induction on cardiac conduction in opiate users. Ann Intern Med 2003; 139: 154-155.
20. Sticherling C, Schaer BA, Ammann P, Maeder M, Osswald S. Methadone-induced Torsade de pointes tachycardias. Swiss Med Wkly 2005; 135: 282-285.
21. Singh N, Singh HK, Singh PP, Khan IA. Cocaine-induced torsades de pointes in idiopathic long Q-T syndrome. Am J Ther 2001; 8: 299-302.
22. Zareba W, Moss AJ, Schwartz PJ, et al. Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med 1998; 339: 960-965.
23. Garson A Jr, Dick M 2nd, Fournier A, et al. The long QT syndrome in children. An international study of 287 patients. Circulation 1993; 87: 1866-1872.